Foreseen Biotechnology
PrivateCompany Overview
Foreseen Biotechnology is a biotechnology company that develops a high-throughput integrated translational proteomics platform and AI-based analytics to discover novel therapeutic targets for cancer, inflammatory, autoimmune, and neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Foreseen Biotechnology Comparables
Compare Foreseen Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Protai | 85% | |
| Sapient | 76% | |
| Recursion Pharmaceuticals | 74% | |
Foreseen Biotechnology Funding Rounds
Historical fundraising activity
Foreseen Biotechnology Investors
Notable investors and investment history
Foreseen Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Foreseen Biotechnology's valuation, stock price, and market status.